学科主题基础医学
PPAR alpha agonist fenofibrate improves diabetic nephropathy in db/db mice
Park, CW1; Zhang, Y1; Zhang, X1; Wu, J1; Chen, L1; Cha, DR1; Su, D1; Hwang, MT1; Fan, X1; Davis, L1; Striker, G1; Zheng, F1; Breyer, M1; Guan, Y1
关键词pPAR alpha type II diabetes diabetic nephropathy fenofibrate
刊名KIDNEY INTERNATIONAL
2006-05-01
DOI10.1038/sj.ki.5000209
69期:9页:1511-1517
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Urology & Nephrology
研究领域[WOS]Urology & Nephrology
关键词[WOS]ACTIVATED RECEPTOR-GAMMA ; INSULIN-RESISTANCE ; CARDIOVASCULAR-DISEASE ; RENAL INJURY ; RATS ; EXPRESSION ; GLOMERULOSCLEROSIS ; ROSIGLITAZONE ; COMPLICATIONS ; TRIGLYCERIDES
英文摘要

Peroxisome proliferator-activated receptor alpha (PPAR alpha) is a member of the ligand-activated nuclear receptor superfamily, and plays an important role in lipid metabolism and glucose homeostasis. The purpose of this study is to determine whether the activation of PPAR alpha by fenofbrate would improve diabetes and its renal complications in type II diabetes mellitus. Male C57 BLKS db/db mice and db/m controls at 8 weeks of age were divided to receive either a regular diet chow (db/db, n = 8; db/m, n = 6) or a diet containing fenofibrate (db/db, n = 8; db/m, n = 7). Mice were followed for 8 weeks. Fenofibrate treatment dramatically reduced fasting blood glucose (P < 0.001) and HbA1c levels (P < 0.001), and was associated with decreased food intake (P < 0.01) and slightly reduced body weight. Fenofibrate also ameliorated insulin resistance (P < 0.001) and reduced plasma insulin levels (P < 0.05) in db/db mice. Hypertrophy of pancreatic islets was decreased and insulin content markedly increased (P < 0.05) in fenofibrate-treated diabetic animals. In addition, fenofibrate treatment significantly reduced urinary albumin excretion (P < 0.001). This was accompanied by dramatically reduced glomerular hypertrophy and mesangial matrix expansion. Furthermore, the addition of fenofibrate to cultured mesangial cells, which possess functional active PPAR alpha, decreased type I collagen production. Taken together, the PPAR alpha agonist fenofibrate dramatically improves hyperglycemia, insulin resistance, albuminuria, and glomerular lesions in db/db mice. The activation of PPAR alpha by fenofibrate in mesangial cells may partially contribute to its renal protection. Thus, fenofibrate may serve as a therapeutic agent for type II diabetes and diabetic nephropathy.

语种英语
WOS记录号WOS:000237238400010
引用统计
被引频次:113[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
版本出版稿
条目标识符http://ir.bjmu.edu.cn/handle/400002259/51632
专题北京大学基础医学院_生理学与病理生理学系
作者单位1.Mt Sinai Sch Med, Dept Med & Geriatr, New York, NY USA
2.Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA
3.Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN 37232 USA
4.Peking Univ, Hlth Sci Ctr, Dept Physiol, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Park, CW,Zhang, Y,Zhang, X,et al. PPAR alpha agonist fenofibrate improves diabetic nephropathy in db/db mice[J]. KIDNEY INTERNATIONAL,2006,69(9):1511-1517.
APA Park, CW.,Zhang, Y.,Zhang, X.,Wu, J.,Chen, L.,...&Guan, Y.(2006).PPAR alpha agonist fenofibrate improves diabetic nephropathy in db/db mice.KIDNEY INTERNATIONAL,69(9),1511-1517.
MLA Park, CW,et al."PPAR alpha agonist fenofibrate improves diabetic nephropathy in db/db mice".KIDNEY INTERNATIONAL 69.9(2006):1511-1517.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
PPAR alpha agonist f(201KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Park, CW]的文章
[Zhang, Y]的文章
[Zhang, X]的文章
百度学术
百度学术中相似的文章
[Park, CW]的文章
[Zhang, Y]的文章
[Zhang, X]的文章
必应学术
必应学术中相似的文章
[Park, CW]的文章
[Zhang, Y]的文章
[Zhang, X]的文章
相关权益政策
暂无数据
收藏/分享
文件名: PPAR alpha agonist fenofibrate improves diabetic nephropathy in db db mice.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。